China's Morningside leads $40m funding in gene therapy developer Apic Bio

China's Morningside leads $40m funding in gene therapy developer Apic Bio

08 January, 2019

Apic Bio Morningside Venture Capital

Printed by Unregistered user on Wed, 06 Aug 2025 06:36:04 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

Read more from Greater China

Trustar Capital raises $626m RMB M&A fund targeting control buyouts in China

Venture Capital

PaXini closes JD-led deal; raises nearly $140m in four months